Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a first-in-class chemical inhibitor that precisely and selectively targets the ATAC ...
In a media release on Jan. 22, it was revealed that a group of scientists from the Agency for Science, Technology and ...
Researchers visualized ALK fusion proteins in real time. They showed that ALK inhibitors reshape flexible protein regions to ...
Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...
In a groundbreaking advancement for cancer treatment, a research team led by Professor Xiang David Li from the Department of Chemistry at The University of Hong Kong (HKU) has made significant strides ...
MedPage Today on MSN
Mutant wolves and cancer; lung cancer in never-smokers; saving female sexual anatomy
News, features, and commentary about cancer-related issues ...
News-Medical.Net on MSN
Understanding tumor growth patterns helps guide treatment after lung cancer
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announced today that its 2026 funding opportunities are officially open for applications. Despite being the leading ...
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results